Skip to main content

Table 4 Subgroup analysis of the overall survival. Despite the histological type, a survival benefit from gastric resection was observed in patients who did not have distant lymph node or liver metastasis

From: The impact and optimal indication of non-curative gastric resection for stage IV advanced gastric cancer diagnosed during surgery: 10 years of experience at a single institute

Condition Tubular adenocarcinoma Non-tubular adenocarcinoma (por, sig, others)
P(+) and/or CY(+), LN(−)H(−) Resection (n = 9) MST; 3.1 years No-resection (n = 3) MST; 0.6 years Resection (n = 25) MST; 1.4 years No-resection (n = 18) MST; 0.8 years
p < 0.01 p = 0.034
P(−)CY(−), LN(+) or H(+) Resection (n = 5) MST; 1.7 years No-resection (n = 2) MST; 1.2 years Resection (n = 1) survival time; 1.0 years No-resection (n = 3) MST; 1.6 years
p = 0.819